The Reynold Spector Award recognizes excellence in research and/or teaching in clinical pharmacology.
The David Lehr Research Award is intended to extend funding for preclinical or clinical research directed towards improving human health.
The June issue of The Pharmacologist announces ASPET’s 2015 Call for Award Nominations. Submit your nominations by September 15, 2014.
Thank you to everyone who submitted a proposal for Round 1 of the BIG IDEAS INTIATIVE. Those selected to further develop their proposal for Round 2 have now been notified. Stay tuned for more details this Fall!
Forgot your password?
Find us on the popular social networks
ASPET Members: We are still accepting Award Nominations for 2015 through September 15, 2014. Send in your nominations soon!
The Foundation for the National Institutes of Health has issued a call for nominations for the Lurie Prize in Biomedical Sciences.
FASEB provided comments to the National Institute for General Medical Sciences (NIGMS) on a proposed funding mechanism that would provide financial support for an investigator’s entire research program rather than individual research projects.
Take a look at what's happening at ASPET. View the current edition of our eNewsletter.
The Federation of American Societies for Experimental Biology (FASEB) has announced its third annual BioArt competition.
The National Institute of General Medical Sciences (NIGMS) has announced the requirements and registration information for its “Stories of Basic Science to Medical Advances” Challenge.
The June issue of the The Pharmacologist is now available. The new issue (Volume 56, Issue 2) features an article titled "Stamping Out Drug Tampering" by Dr. Rebecca Anderson. Also in this issue, read about EB 2014 in review, new ASPET awards for 2015, an in-depth interview with Dr. Chip Rutledge, and much more.
Read through our
archive of past news and access links to previous eNewsletters, member news, science policy updates, and more.
Last summer, NIH released a notice that encouraged institutions to develop Individual Development Plans (IDPs) for graduate students and postdoctoral researchers. Yesterday, NIH posted a revised policy to clarify implementation and reporting expectations for this policy, effective for progress reports received on/after October 1, 2014.
The NIH announced a “new collaborative initiative to improve human health by exploring poorly understood genes that have the potential to be modified by medicines,” as part of the NIH Common Fund’s Illuminating the Druggable Genome (IDG) project.
Last year, the NDD United campaign—founded and led by the Coalition for Health Funding (CHF), of which ASPET is a member—released a report to share the stories of individuals harmed by federal budget cuts titled Faces of Austerity: How Budget Cuts Have Made Us Sicker, Poorer and Less Secure.
When the Senate Labor/HHS Appropriations Subcommittee approved its spending bill in June providing NIH a $605 million increase, there was some optimism that Congress would be able to pass some of its funding bills by the time FY 2015 begins on October 1.
ASPET has endorsed Senator Tom Harkin’s (D-IA) proposed legislation, “Accelerating Biomedical Research Act,” that would help increase funding for the NIH.
©The American Society for Pharmacology and Experimental Therapeutics (ASPET)9650 Rockville Pike, Bethesda, Maryland 20814-3995
ASPET.org is best viewed with Internet Explorer 7+, Firefox 3.5+ and Safari 3+.